![Martha E. Vincent](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martha E. Vincent
Direttore Tecnico/Scientifico/R&S presso Agensys, Inc.
Profilo
Martha E.
Vincent is currently the Vice President of Clinical Research & Development at Agensys, Inc. Prior to this, she was the VP of Medical Affairs & Clinical Development at Amgen, Inc. from 1995 to 2004.
Dr. Vincent holds a doctorate degree from the University of Medicine & Dentistry of New Jersey and an undergraduate degree from Iowa State University.
Posizioni attive di Martha E. Vincent
Società | Posizione | Inizio |
---|---|---|
Agensys, Inc.
![]() Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/2004 |
Precedenti posizioni note di Martha E. Vincent
Società | Posizione | Fine |
---|---|---|
AMGEN INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2004 |
Formazione di Martha E. Vincent
Iowa State University | Undergraduate Degree |
University of Medicine & Dentistry of New Jersey | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
AMGEN INC. | Health Technology |
Aziende private | 1 |
---|---|
Agensys, Inc.
![]() Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Commercial Services |
- Borsa valori
- Insiders
- Martha E. Vincent